Tune in on Oct. 22 for our Development of Anti-CCR8 Ab - Mechanisms and Clinical Results Webinar! We will address the novel therapeutic target C-C chemokine receptor 8 (CCR8), its role in regulatory T cell (Treg) activity and immunosuppression. Register: www.sitcancer.org/edu/webinars... 🧪

Submit your research for 2026 Spring Scientific. The program will feature in-depth explorations of recent scientific breakthroughs that address the advancement of novel immuno-oncology agents. Submit your abstract today! sitcancer.org/edu/2026-spr...

New Journal for ImmunoTherapy of Cancer article: Genome editing or small molecule inhibition of KMT5A in CAR-T cells enhances antitumor immunity bit.ly/4gszuLy #JITC #ImmunoSky

From early detection to survival, #AI is transforming cancer care! At #SITC25, explore the latest data, #research and insights on how AI is advancing immune-oncology. Join the global IO community driving progress at SITC’s 40th Anniversary Meeting: www.sitcancer.org/2025/home

Congratulations to these two pioneers in #immunotherapy, an incredible honor!

A Meaningful Week of Science at the WCLC25 - Narjust Florez @narjustflorezmd.bsky.social oncodaily.com/voices/narju... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WCLC25

Congratulations to SITC's 2025 Fellowship recipients, we are honored to support the next generation of leaders in immuno-oncology!

Read the Sept. edition of the #JITC Digest! Access insights on dendritic cells from Editor-in-Chief Dr. Michael Lotze and view his selection of cutting-edge research. Explore the evolving IO landscape with two new JITC Special Series publications. Read the digest: www.sitcancer.org/blogs/jitc-p...

Use the Career Connections Online Job Board to find the right candidates for your open job positions. #SITC is offering a 40% discount on a single, 3- or 5-pack of job posts with code SITC40YEARS or SITC40YEARSPACK. This offer expires Nov. 30! Learn more: careerconnections.sitcancer.org

Gain in-depth education on all aspects of clinical implementation of IO for skin cancers! Learn from leading experts and advance your education with SITC's #virtual ACI: A Focus on Skin Cancers program Oct. 3. View topics: www.sitcancer.org/edu/aci/skin... 🧪 #LearnACI #MedSky #OncSky

Wonderful to see Dr. Elizabeth Jaffee, SITC 2024 keynote speaker, sharing insights and highlights with the @yalecancer.bsky.social community! Her important presentation continues to advance scientific exchange in IO.

Exciting work from @haeryfarlab.bsky.social! Their latest study explores the role of #MAIT cells in #BladderCancer. Check out this cutting-edge science in a full open-access article in the Journal for ImmunoTherapy of cancer: jitc.bmj.com/content/13/9... #JITC #ImmunoSky #MedSky

The SITC #Sparkathon 2026 topic is “Next-generation Cellular Therapies, T cell Engagers, and Combinations”. Apply by Nov. 19 and learn more about leadership development, collaborations & scientific exchange. sitcancer.org/sparkathon #ECR

LBA submissions for #SITC25 are due today at 5 p.m. PT. Do not miss this opportunity to share your exciting new research at our 40th Anniversary Annual Meeting. Learn more and submit here: sitcancer.org/2025/abstrac...

Post-Trastuzumab Deruxtecan Outcomes in Metastatic Breast Cancer @ptarantinomd.bsky.social oncodaily.com/voices/derux... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #TrastuzumabDeruxtecan #mBC #BreastCancer

Check out the Venkatesh lab's new paper in Nature, where we uncover how neural activity drives small cell lung cancer (SCLC) progression. Grateful to my PI Humsa Venkatesh, my co-first author Solomiia Savchuk, & a huge thanks to all the incredible co-authors. www.nature.com/articles/s41...

SITC is excited to join @fda.gov and @theaacr.bsky.social today to collaborate on a workshop to explore considerations for the development & application of novel endpoints in oncology drug development. Thank you to Dr. Alexandra Snyder representing #SITC for co-chairing this event. #SITCquestfor100

We are excited to announce the 2026 SITC EU Immuno-Oncology Drug Development Summit. Coming Sept. 2026 in Lausanne, Switzerland. This program will discuss best practices for modern IO drug development & the next wave of IO therapeutics. Join the waitlist: t.co/JhPLTpSvdb 🧪

Attend tomorrow's Unlocking the Power of Spatial Omics with AI webinar to discuss how AI can unlock the full potential of spatial omics, driving advancements in immuno-oncology! Register now for this cutting-edge program: t.co/hZ2FCezItx

One week left to submit your Late-breaking Abstracts – Clinical Only (LBAs) for #SITC25! Submit your cutting-edge research by Sept. 15, 2025. Additional oral presentation opportunities available! sitcancer.org/2025/abstrac... #immunotherapy

Manage toxicities associated with bispecific tarlatamab for small cell lung cancer! Learn from a panel of experts during SITC’s #virtual Advances in Cancer Immunotherapy: A Focus on Lung Cancers program Sept. 12. Learn more: ow.ly/I7HJ50WT8wW 🧪 @drjnaidoo.bsky.social

Master the core principles of #tumor #immunology and #cancer #immunotherapy. Register for SITC Winter School 2026 and learn from the leading experts in the field of #immunotherapy. Held in Boston, MA or virtually: sitcancer.org/edu/wintersc...

#SITC25 Science Preview: Join Drs. Michael Lotze @news.upmc.com, Wim Vos, Stephane Champiat @mdanderson.bsky.social, Eric Deutsch @gustaveroussy.fr & Di Dong in the session, “Imaging, Radiomics and Integrated Biomarkers in IO”. View session details: www.sitcancer.org/2025/schedul...

New Journal for ImmunoTherapy of Cancer position article and guidelines: Constructing the cure: engineering the next wave of antibody and cellular immune therapies bit.ly/3HYCbrs #JITC #ImmunoSky #MedSky

Abstract submission deadline for #SITC25 is Sept. 15 for Late-breaking Abstracts. All accepted Abstracts will have the opportunity to present a poster in the Poster Hall and are published in JITC. Learn more: sitcancer.org/2025/abstrac...

Registration is now open for the 2026 Spring Scientific: Next-generation #Cellular Therapies, T #cell Engagers, and Combinations! This year's program will be held in Tucson, AZ & Virtual on March 25–27, 2026. Learn more about the #SITC Spring Scientific & Register: sitcancer.org/SpringScientific

Journal for ImmunoTherapy of Cancer editors will be honored for their leadership in IO! Congrats Sjoerd H. van der Burg, recipient of the Pedro J. Romero Service to JITC award. We honor Ignacio (Nacho) Melero & Michael Lotze, newly elected FAIO fellows. Details: www.sitcancer.org/2025/schedul...

Find talented candidates for your open job positions by using the Career Connections Online Job Board. Through Nov. 30, save 40% on a single, 3- or 5- pack of job posts using code SITC40YEARS or SITC40YEARSPACK. Learn more here: careerconnections.sitcancer.org

Stay in the know with #SITC! Explore our upcoming events, webinars, and important dates by looking at our calendar. Learn More: sitcancer.org/get-involved... #Immunotherapy

The Primer on #Tumor Immunology and Cancer Immunotherapy™ is designed to provide a foundation for understanding core immunology principles as they relate to basic and #clinical #research in immunotherapy of cancer. To learn more & to register, visit: t.co/vwjrCdpvSl 🧪

Integrate immunotherapy into your clinical practice with a Certificate in #Cancer #Immunotherapy from SITC. Explore eight expert-led modules, approved for CME, CNE, CPE & MOC credit. Register at www.sitcancer.org/certificate

See what is new with SITC by checking out the August edition of the SITC Immune Monitor. Learn about upcoming programs and the most recent society news. Read more here: www.sitcancer.org/blogs/sitc-c... #CancerIO #SITC #Immune2Cancer

Manage non-small cell lung cancer in the perioperative, metastatic, and second-line settings with insights from Advances in Cancer Immunotherapy™: A Focus on Lung Cancers Sept. 12. This live virtual program is CME, CNE, CPE and MOC certified. 🧪 View topics: www.sitcancer.org/edu/aci/lung...

We’re excited for SITC #Sparkathon 2026! This innovative event brings together brilliant young investigators in #cancer #IO to spark groundbreaking ideas & collaborations. Applications are due by Nov. 19. Learn more: www.sitcancer.org/sparkathon #ECR

New Journal for ImmunoTherapy of Cancer article: First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors bit.ly/45yTdUQ 🧪 #JITC #ImmunoSky #MedSky

Looking to advance your career in #cancer #immunotherapy? Look no further than SITC Winter School. Held Feb. 16–18, 2026, learn from industry-leading experts who will discuss biomarker technology, validation and clinical integration. Register now at sitcancer.org/edu/winterschool

SITC Sparkathon class of 2026 brings together early career investigators with established leaders in cancer immunotherapy to foster leadership development, collaborations & scientific exchange. March 23–25, 2026, in Tucson, AZ. #immunotherapy #cancer #ECR sitcancer.org/sparkathon

New Journal for ImmunoTherapy of Cancer commentary: Immunotherapy versus lenvatinib in hepatocellular carcinoma: the need for granular data and prospective validation bit.ly/4lvYhiI 🧪 #JITC #OncSky #MedSky #ImmunoSky

#SITC25 Science Preview: Explore immuno ADCs with Drs. Claire Friedman, Eli Lilly & Co, Alfred Zippelius @unibas.ch, Margaret K. Callahan, @uconn.bsky.social, Paolo Tarantino @danafarber.bsky.social - Harvard Medical Center and Greg Thurber @umich.edu. View session details: ow.ly/okIR50WJxjg

Please consider supporting cancer research and cancer patient care. We are riding our bikes on Sep 6. Even a few $$ can go a long way. Let’s end cancer!! www.rideclosertofree.org/participants...

Attend tomorrow's #SITC #NCI Assessing the #Tumor #Microenvironment with Systems #Immunology webinar about cutting-edge #computational tools & analytical approaches that reveal the complexities of the #TME & #tumor #immunobiology! Register now for this exciting #IO program: sitcancer.org/CompIO

Congratulations to @danafarber.bsky.social’s Cathy Wu, MD, who was selected by Society for Immunotherapy of Cancer as the recipient of the 2026 Richard V. Smalley Memorial Award and Lectureship. ➡️ bit.ly/4octIB3

Society for Immunotherapy of Cancer Celebrates 40 Years with Special Awards#Cancer_Immunotherapy#SITC #40th_Anniversary

The Aug. issue of the #JITC Digest highlights the 2nd WIC APAC in Singapore, IO growth across the region and young investigators headed to #SITC25! View key JITC publication trends and major recognitions in the field. Explore the full Digest: ow.ly/PmXF50WIWB3

FYI: @sitcancer.bsky.social and NCI sponsored free webinar focused on assessing TME with systems Immunology,as part of the Computational Immuno-Oncology Series is taking place tomorrow, August 21st at 12 PM ET. Register at: sitcancer.org/CompIO

Enduring materials are available for the #SITC Summit on the Future of #Neoadjuvant #Clinical Trial Design! This summit highlighted recent advances, opportunities & challenges in the field of #neoadjuvant #immunotherapy! View for FREE: sitcancer.org/viewdocument/sitc-summit-on-the-future-of-neoadj

Applications are open for SITC Sparkathon 2026 to be held on March 23–25, 2026, in Tucson, AZ. This year's topic focuses on Next-generation Cellular Therapies, T cell Engagers, and Combinations. Deadline is Nov. 19, 2025 #sparkathon #Immunotherapy sitcancer.org/sparkathon

Explore emerging perspectives on toxicities following CAR T and bispecific therapies. Learn from a panel of experts with SITC’s #virtual ACI: A Focus on Hematologic Malignancies program Aug. 25. Learn more & register: www.sitcancer.org/edu/aci/hema... #LearnACI

Mark your calendars! ASPIRE-IOTOX Symposium April 24-25, 2026 at MD Anderson Cancer Center #irAE #immunotherapy @sitcancer.bsky.social @ascocancer.bsky.social @funchainmd.bsky.social @kerryreynoldsmd.bsky.social @kmittalmd.bsky.social @mdanderson.bsky.social

New Journal for ImmunoTherapy of Cancer review: Genetic drivers of tumor microenvironment and immunotherapy resistance in non-small cell lung cancer: the role of KEAP1, SMARCA4, and PTEN mutations bit.ly/3Hzc6yO #JITC #MedSky #OncSky 🧪